Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Phase 2 Study of LY3209590 in Participants With Type 2 Diabetes Mellitus

ClinicalTrials.gov ID: NCT04450394

Public ClinicalTrials.gov record NCT04450394. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 20, 2026, 1:50 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Parallel, Comparator-Controlled Trial to Evaluate the Safety and Efficacy of LY3209590 in Insulin-Naïve Patients With Type 2 Diabetes Mellitus

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The reason for this study is to see if the study drug LY3209590 is safe and effective in participants with type 2 diabetes.

Study identification

NCT ID
NCT04450394
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Eli Lilly and Company
Industry
Enrollment
278 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 1, 2020 (Actual)
Primary completion
Oct 8, 2021 (Actual)
Completion
Oct 8, 2021 (Actual)
Last update posted
Nov 2, 2022

2020 – 2021

United States locations

U.S. sites
31
U.S. states
17
U.S. cities
29
Facility City State ZIP Site status
Syed Research Consultants Llc Sheffield Alabama 35660 —
National Research Institute - Huntington Park Huntington Park California 90255 —
National Research Institute - Wilshire Los Angeles California 90057 —
Catalina Research Institute, LLC Montclair California 91763 —
Encompass Clinical Research Spring Valley California 91978 —
CMR of Greater New Haven Waterbury Connecticut 06708 —
ALL Medical Research, LLC Cooper City Florida 33024 —
Jellinger and Lerman, MD PA dba The Center for Diabetes and Endocrine Care Fort Lauderdale Florida 33312 —
Suncoast Research Group Miami Florida 33135 —
New Horizon Research Center Miami Florida 33165 3338 —
Suncoast Clinical Research New Port Richey Florida 34652 —
Rophe Adult and Pediatric Medicine Union City Georgia 30291 —
Elite Clinical Trials Blackfoot Idaho 83221 —
Rocky Mountain Clinical Research Idaho Falls Idaho 83404 —
Elite Clinical Trials Rexburg Idaho 83440 —
Iowa Diabetes and Endocrinology Research Center West Des Moines Iowa 50265 —
Cotton O'Neil Diabetes and Endocrinology Center Topeka Kansas 66606 —
L-MARC Research Center Louisville Kentucky 40213 —
Endocrine and Metabolic Consultants Rockville Maryland 20852 —
Sky Clin Resch - Quinn HC Ridgeland Mississippi 39157 —
Lillestol Research LLC Fargo North Dakota 58104 —
Intend Research, LLC Norman Oklahoma 73069 —
Preferred Primary Care Physicians Uniontown Pennsylvania 15401 —
Holston Medical Group Bristol Tennessee 37620 —
Texas Diabetes & Endocrinology, P.A. Austin Texas 78731-4309 —
Dallas Diabetes Research Center Dallas Texas 75230 —
Juno Research Houston Texas 77040 —
Juno Research - Gessner Houston Texas 77074 —
Southern Endocrinology Associates Mesquite Texas 75149 —
Consano Clinical Research, LLC Shavano Park Texas 78231 —
Rainier Clinical Research Center Renton Washington 98057 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 33 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04450394, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 2, 2022 · Synced Oct 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04450394 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →